CIK 0001709941 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
BioAge Labs, Inc.
Sign in to watch- Ticker
- BIOA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 474721157
- Phone
- 510-806-1445
- Business address
- 5885 HOLLIS STREET, SUITE 370, EMERYVILLE, CA, 94608
- 4 Planned sale Principal Accounting Officer sold 62,566 shares at an average $25.20 ($1,576,752)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Option exercise Chief Financial Officer acquired 3,542 shares (option exercise)
- 4 Planned sale Chief Medical Officer sold 8,820 shares at $17.81 ($157,084)
- 4 Planned sale Chief Medical Officer sold 7,433 shares at $20.30 ($150,890)
- 4 Option exercise Chief Financial Officer acquired 3,542 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale Chief Medical Officer sold 7,433 shares at $18.75 ($139,369)
- 4 Option exercise Chief Financial Officer acquired 3,541 shares (option exercise)
- 4 Option exercise Chief Financial Officer acquired 3,542 shares (option exercise)
- 4 Planned sale Chief Financial Officer sold 27,000 shares at an average $19.70 ($531,828)
Page 1 of 4 · 61 filings